Home Healthcare Healthcare Services Formulation Development Outsourcing Market

Formulation Development Outsourcing Market Size, Share & Trends Analysis Report By Service (Pre-Formulation Service, Formulation Optimization), By Dosage Form (Injectable, Oral, Topical, Other Dosage Forms), By Applications (Oncology, Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular, Other Applications), By End-User (Pharmaceutical and Biopharmaceutical Companies, Government and Academic Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Jay Mehta | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Formulation Development Outsourcing Market, By Service 2022-2034 (USD MILLION/ Units)
    1. Pre-Formulation Service
    2. Formulation Optimization
  2. Formulation Development Outsourcing Market, By Dosage Form 2022-2034 (USD MILLION/ Units)
    1. Injectable
    2. Oral
    3. Topical
    4. Other Dosage Forms
  3. Formulation Development Outsourcing Market, By Applications 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Genetic Disorders
    3. Neurology
    4. Infectious Diseases
    5. Respiratory
    6. Cardiovascular
    7. Other Applications
  4. Formulation Development Outsourcing Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical and Biopharmaceutical Companies
    2. Government and Academic Institutes
  5. Regional Formulation Development Outsourcing Market
    1. North America
      1. North America Formulation Development Outsourcing Market By Service 2022-2034 (USD MILLION/ Units)
        1. Pre-Formulation Service
        2. Formulation Optimization
      2. North America Formulation Development Outsourcing Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
        3. Topical
        4. Other Dosage Forms
      3. North America Formulation Development Outsourcing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Neurology
        4. Infectious Diseases
        5. Respiratory
        6. Cardiovascular
        7. Other Applications
      4. North America Formulation Development Outsourcing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Government and Academic Institutes
      5. U.S.
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      6. Canada
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
    2. Europe
      1. Europe Formulation Development Outsourcing Market By Service 2022-2034 (USD MILLION/ Units)
        1. Pre-Formulation Service
        2. Formulation Optimization
      2. Europe Formulation Development Outsourcing Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
        3. Topical
        4. Other Dosage Forms
      3. Europe Formulation Development Outsourcing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Neurology
        4. Infectious Diseases
        5. Respiratory
        6. Cardiovascular
        7. Other Applications
      4. Europe Formulation Development Outsourcing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Government and Academic Institutes
      5. U.K.
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      6. Germany
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      7. France
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      8. Spain
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      9. Italy
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      10. Russia
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      11. Nordic
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      12. Benelux
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      13. Rest of Europe
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
    3. APAC
      1. APAC Formulation Development Outsourcing Market By Service 2022-2034 (USD MILLION/ Units)
        1. Pre-Formulation Service
        2. Formulation Optimization
      2. APAC Formulation Development Outsourcing Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
        3. Topical
        4. Other Dosage Forms
      3. APAC Formulation Development Outsourcing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Neurology
        4. Infectious Diseases
        5. Respiratory
        6. Cardiovascular
        7. Other Applications
      4. APAC Formulation Development Outsourcing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Government and Academic Institutes
      5. China
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      6. Korea
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      7. Japan
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      8. India
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      9. Australia
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      10. Taiwan
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      11. South East Asia
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      12. Rest of Asia-Pacific
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
    4. Middle East and Africa
      1. Middle East and Africa Formulation Development Outsourcing Market By Service 2022-2034 (USD MILLION/ Units)
        1. Pre-Formulation Service
        2. Formulation Optimization
      2. Middle East and Africa Formulation Development Outsourcing Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
        3. Topical
        4. Other Dosage Forms
      3. Middle East and Africa Formulation Development Outsourcing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Neurology
        4. Infectious Diseases
        5. Respiratory
        6. Cardiovascular
        7. Other Applications
      4. Middle East and Africa Formulation Development Outsourcing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Government and Academic Institutes
      5. UAE
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      6. Turkey
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      7. Saudi Arabia
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      8. South Africa
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      9. Egypt
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      10. Nigeria
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      11. Rest of MEA
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
    5. LATAM
      1. LATAM Formulation Development Outsourcing Market By Service 2022-2034 (USD MILLION/ Units)
        1. Pre-Formulation Service
        2. Formulation Optimization
      2. LATAM Formulation Development Outsourcing Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injectable
        2. Oral
        3. Topical
        4. Other Dosage Forms
      3. LATAM Formulation Development Outsourcing Market By Applications 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Genetic Disorders
        3. Neurology
        4. Infectious Diseases
        5. Respiratory
        6. Cardiovascular
        7. Other Applications
      4. LATAM Formulation Development Outsourcing Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Government and Academic Institutes
      5. Brazil
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      6. Mexico
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      7. Argentina
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      8. Chile
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      9. Colombia
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
      10. Rest of LATAM
        1. Pre-Formulation Service
        2. Formulation Optimization
        3. Injectable
        4. Oral
        5. Topical
        6. Other Dosage Forms
        7. Oncology
        8. Genetic Disorders
        9. Neurology
        10. Infectious Diseases
        11. Respiratory
        12. Cardiovascular
        13. Other Applications
        14. Pharmaceutical and Biopharmaceutical Companies
        15. Government and Academic Institutes
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.